Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., ...
Clinical Trials Arena on MSN
JPM26: Intellia Therapeutics hopeful on CRISPR safety despite patient deathIntellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Intellia Therapeutics Inc. shares dropped after the company said a patient died after suffering liver damage in a clinical trial for the company’s gene-editing treatment. The patient, who was in his ...
The FDA has officially limited the label of Sarepta Therapeutics’ Elevidys, putting an end to a whirlwind few months that saw the abrupt departure—and reinstatement—of top agency official Vinay Prasad ...
Shares of Intellia Therapeutics (NTLA) crashed ~28% in the premarket on Friday after the company disclosed that a patient who experienced a liver-related adverse event in a Phase 3 trial for its nex-z ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback